Dr. Ahmed Hamed Rashad, a highly esteemed Clinical Oncologist, has recently been appointed as the Deputy Director of the Clinical Oncology Department at NEMROCK (National Cancer Institute), Cairo University (Kasr Alainy) in March 2023. This appointment further strengthens Dr. Hamed’s influential role in the field of oncology and his dedication to advancing cancer research and patient care. With his extensive experience and background in oncology, including his association with the prestigious Fred Hutchinson Cancer Research Center in Seattle, United States, Dr. Ahmed Hamed Rashad is poised to make significant contributions to the field of cancer treatment and research in Egypt. Dr. Ahmed Hamed Rashad is a highly accomplished clinical oncologist with extensive experience in the diagnosis and treatment of various types of cancer. He has a particular interest in treatment of hematological cancers, including lymphomas, leukemia and multiple myeloma. In addition to, stem cell transplant including autologous and allogeneic transplant. Dr. Hamed obtained his BSc degree before pursuing further training in the United States. He completed his residency in radiation oncology at the Fred Hutchinson Cancer Research Center in Seattle, United States where he gained valuable experience in hematological cancers as well as stem cell transplant, also clinical research and the development of new cancer treatments.
He has also published several research papers in leading medical journals, demonstrating his commitment to advancing the field of oncology through scientific research. In addition to his clinical work, Dr. Ahmed Hamed is an active member of the research group at Cairo Cure, where he collaborates with other experts in the field to explore new approaches to cancer treatment. He is also a sought-after speaker and has given presentations at numerous conferences and events around the world. Overall, Dr. Ahmed Hamed Rashad is a highly accomplished and respected clinical oncologist, whose expertise and dedication to the field of oncology make him a valuable asset to any medical team.